CN Stock MarketDetailed Quotes

002550 Changzhou Qianhong Biopharma

Watchlist
  • 5.33
  • -0.03-0.56%
Market Closed Aug 22 15:00 CST
6.82BMarket Cap27.76P/E (TTM)

Changzhou Qianhong Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-19.04%855.6M
-24.19%461.1M
-21.24%1.81B
-11.09%1.47B
-7.05%1.06B
10.14%608.22M
22.86%2.3B
20.50%1.65B
30.23%1.14B
41.16%552.22M
Operating revenue
-19.04%855.6M
-24.19%461.1M
-21.24%1.81B
-11.09%1.47B
-7.05%1.06B
10.14%608.22M
22.86%2.3B
20.50%1.65B
30.23%1.14B
41.16%552.22M
Other operating revenue
-70.17%995.45K
----
358.99%5.17M
----
126.10%3.34M
----
10.02%1.13M
----
189.36%1.48M
----
Total operating cost
-30.15%654.23M
-33.42%344.36M
-16.33%1.67B
-6.59%1.3B
-0.81%936.63M
14.65%517.22M
15.25%1.99B
15.53%1.39B
23.42%944.29M
41.68%451.12M
Operating cost
-34.19%404.71M
-41.52%216.07M
-27.23%1.03B
-16.26%836.54M
-12.52%614.97M
12.42%369.5M
35.85%1.41B
32.94%998.98M
43.29%702.99M
51.55%328.68M
Operating tax surcharges
48.07%13.06M
14.28%6.39M
19.31%20.4M
16.11%15.08M
-3.29%8.82M
-7.30%5.59M
-6.79%17.1M
2.14%12.99M
29.64%9.12M
141.96%6.03M
Operating expense
-27.54%157.48M
-11.21%78.39M
-6.62%393.86M
-8.93%308.74M
6.76%217.34M
13.64%88.29M
-8.99%421.76M
4.65%339M
5.48%203.58M
4.46%77.69M
Administration expense
-17.47%51.85M
0.20%26.16M
6.55%131.76M
14.78%93.67M
21.71%62.82M
9.08%26.11M
-3.32%123.66M
-2.78%81.61M
-6.47%51.61M
5.88%23.94M
Financial expense
42.92%-4.75M
-101.84%-131.26K
91.38%-6.39M
92.35%-6.74M
84.38%-8.33M
101.43%7.15M
-1,429.75%-74.2M
-703.53%-88.14M
-556.05%-53.33M
137.44%3.55M
-Interest expense (Financial expense)
-74.87%982.02K
-55.98%726.67K
13.22%5.93M
34.73%5.54M
34.62%3.91M
-12.51%1.65M
215.73%5.23M
192.62%4.11M
278.29%2.9M
408.28%1.89M
-Interest Income (Financial expense)
-0.50%-6.21M
50.95%-2.02M
-100.25%-11.3M
-105.66%-8.19M
-156.67%-6.18M
-428.96%-4.12M
-252.63%-5.64M
-4.70%-3.98M
-17.20%-2.41M
35.14%-777.97K
Research and development
-22.22%31.89M
-15.12%17.48M
9.93%97.08M
11.20%53.17M
35.26%41M
83.32%20.59M
24.06%88.31M
8.59%47.81M
10.59%30.31M
-2.54%11.23M
Credit Impairment Loss
-142.83%-3.62M
-173.91%-6.06M
215.42%17.43M
250.15%16.64M
164.11%8.45M
190.02%8.21M
-128.80%-15.1M
-121.44%-11.08M
-1,241.54%-13.19M
-166.58%-9.11M
Asset Impairment Loss
3,671.19%49.65K
----
-3,685.29%-19.62M
---1.39K
---1.39K
---1.39K
4.27%-518.22K
----
--0
--0
Adjustment items of total operating cost
---0.01
----
----
----
----
---0.01
----
----
----
----
Other net revenue
-78.09%3.19M
-97.67%262.25K
17.75%56.13M
320.08%28.86M
186.84%14.56M
254.18%11.24M
-23.31%47.67M
-124.54%-13.11M
-5,077.46%-16.76M
-69.42%-7.29M
Fair value change income
165.15%858.81K
158.63%430.73K
670.53%771.38K
122.09%440.84K
-10.05%323.9K
-63.32%166.55K
-89.88%100.11K
8.78%198.5K
135.87%360.09K
599.76%454.06K
Invest income
-41.87%549.37K
972.47%3.03M
270.72%8M
143.66%3.65M
112.33%945.07K
127.73%282.36K
-1,244.58%-4.69M
-19.26%-8.35M
4.60%-7.67M
84.45%-1.02M
Asset deal income
--0
----
-55.98%25.35M
--208.74
--0
----
--57.59M
----
----
----
Other revenue
10.67%5.35M
10.95%2.87M
135.25%24.2M
32.99%8.14M
29.65%4.84M
8.15%2.59M
6.76%10.28M
-28.62%6.12M
-47.21%3.73M
-57.31%2.39M
Operating profit
51.88%204.55M
14.45%117.01M
-43.24%204.36M
-20.18%194.34M
-23.40%134.68M
8.97%102.23M
71.97%360.01M
12.35%243.46M
62.45%175.83M
36.94%93.82M
Add:Non operating Income
688.36%1.12M
-98.63%1.83K
-52.01%350.92K
-56.69%25.5M
-99.76%141.92K
-99.77%133.89K
79.92%731.23K
14,884.84%58.89M
18,480.51%58.58M
18,518.53%58.14M
Less:Non operating expense
254.59%231.2K
1,636.66%174.4K
190.70%1.18M
174.83%1.07M
-78.49%65.2K
-93.47%10.04K
10.96%407.28K
15.18%388.05K
32.25%303.18K
20.14%153.74K
Total profit
52.45%205.44M
14.15%116.83M
-43.52%203.52M
-27.55%218.78M
-42.44%134.76M
-32.57%102.36M
72.10%360.33M
39.31%301.96M
116.13%234.11M
120.99%151.8M
Less:Income tax cost
37.56%29.01M
-17.64%15.49M
-38.52%24.85M
-30.47%31.12M
-45.03%21.09M
-27.69%18.81M
75.47%40.42M
36.61%44.76M
65.62%38.36M
82.74%26.01M
Net profit
55.21%176.43M
21.30%101.35M
-44.15%178.67M
-27.04%187.65M
-41.93%113.67M
-33.58%83.55M
71.68%319.91M
39.79%257.2M
129.87%195.75M
130.98%125.8M
Net profit from continuing operation
55.21%176.43M
21.30%101.35M
-44.15%178.67M
-27.04%187.65M
-41.93%113.67M
-33.58%83.55M
71.68%319.91M
39.79%257.2M
129.87%195.75M
130.98%125.8M
Less:Minority Profit
-18.84%-6.37M
-15.20%-2.76M
8.99%-3.19M
8.91%-10.2M
12.35%-5.36M
2.22%-2.4M
-166.56%-3.5M
-88.67%-11.2M
-53.03%-6.11M
-2,507.97%-2.45M
Net profit of parent company owners
53.57%182.79M
21.13%104.11M
-43.77%181.86M
-26.28%197.86M
-41.03%119.03M
-32.98%85.95M
78.60%323.41M
41.32%268.4M
126.42%201.86M
135.93%128.25M
Earning per share
Basic earning per share
56.50%0.1457
23.07%0.0827
-44.00%0.14
-27.68%0.1549
-42.35%0.0931
-34.50%0.0672
66.67%0.25
40.74%0.2142
125.87%0.1615
135.32%0.1026
Diluted earning per share
56.50%0.1457
23.07%0.0827
-44.00%0.14
-27.68%0.1549
-42.35%0.0931
-34.50%0.0672
66.67%0.25
40.74%0.2142
125.87%0.1615
135.32%0.1026
Other composite income
-81.04%-741.72K
-2,850.69%-1.32M
118.33%420.5K
56.43%-1.57M
-159.64%-409.7K
-106.87%-44.83K
-173.72%-2.29M
-14,922.82%-3.59M
4,878.38%687K
2,266.05%652.35K
Other composite income of parent company owners
-81.04%-741.72K
-2,850.69%-1.32M
118.33%420.5K
56.43%-1.57M
-159.64%-409.7K
-106.87%-44.83K
-173.72%-2.29M
-14,922.82%-3.59M
4,878.38%687K
2,266.05%652.35K
Total composite income
55.12%175.69M
19.78%100.02M
-43.61%179.09M
-26.62%186.09M
-42.34%113.26M
-33.96%83.51M
67.65%317.62M
37.86%253.61M
130.71%196.43M
132.06%126.45M
Total composite income of parent company owners
53.48%182.05M
19.65%102.79M
-43.24%182.28M
-25.87%196.29M
-41.44%118.62M
-33.36%85.9M
74.34%321.12M
39.45%264.81M
127.23%202.54M
137.01%128.9M
Total composite income of minority owners
-18.84%-6.37M
-15.20%-2.76M
8.99%-3.19M
8.91%-10.2M
12.35%-5.36M
2.22%-2.4M
-166.56%-3.5M
-88.67%-11.2M
-53.03%-6.11M
-2,507.97%-2.45M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -19.04%855.6M-24.19%461.1M-21.24%1.81B-11.09%1.47B-7.05%1.06B10.14%608.22M22.86%2.3B20.50%1.65B30.23%1.14B41.16%552.22M
Operating revenue -19.04%855.6M-24.19%461.1M-21.24%1.81B-11.09%1.47B-7.05%1.06B10.14%608.22M22.86%2.3B20.50%1.65B30.23%1.14B41.16%552.22M
Other operating revenue -70.17%995.45K----358.99%5.17M----126.10%3.34M----10.02%1.13M----189.36%1.48M----
Total operating cost -30.15%654.23M-33.42%344.36M-16.33%1.67B-6.59%1.3B-0.81%936.63M14.65%517.22M15.25%1.99B15.53%1.39B23.42%944.29M41.68%451.12M
Operating cost -34.19%404.71M-41.52%216.07M-27.23%1.03B-16.26%836.54M-12.52%614.97M12.42%369.5M35.85%1.41B32.94%998.98M43.29%702.99M51.55%328.68M
Operating tax surcharges 48.07%13.06M14.28%6.39M19.31%20.4M16.11%15.08M-3.29%8.82M-7.30%5.59M-6.79%17.1M2.14%12.99M29.64%9.12M141.96%6.03M
Operating expense -27.54%157.48M-11.21%78.39M-6.62%393.86M-8.93%308.74M6.76%217.34M13.64%88.29M-8.99%421.76M4.65%339M5.48%203.58M4.46%77.69M
Administration expense -17.47%51.85M0.20%26.16M6.55%131.76M14.78%93.67M21.71%62.82M9.08%26.11M-3.32%123.66M-2.78%81.61M-6.47%51.61M5.88%23.94M
Financial expense 42.92%-4.75M-101.84%-131.26K91.38%-6.39M92.35%-6.74M84.38%-8.33M101.43%7.15M-1,429.75%-74.2M-703.53%-88.14M-556.05%-53.33M137.44%3.55M
-Interest expense (Financial expense) -74.87%982.02K-55.98%726.67K13.22%5.93M34.73%5.54M34.62%3.91M-12.51%1.65M215.73%5.23M192.62%4.11M278.29%2.9M408.28%1.89M
-Interest Income (Financial expense) -0.50%-6.21M50.95%-2.02M-100.25%-11.3M-105.66%-8.19M-156.67%-6.18M-428.96%-4.12M-252.63%-5.64M-4.70%-3.98M-17.20%-2.41M35.14%-777.97K
Research and development -22.22%31.89M-15.12%17.48M9.93%97.08M11.20%53.17M35.26%41M83.32%20.59M24.06%88.31M8.59%47.81M10.59%30.31M-2.54%11.23M
Credit Impairment Loss -142.83%-3.62M-173.91%-6.06M215.42%17.43M250.15%16.64M164.11%8.45M190.02%8.21M-128.80%-15.1M-121.44%-11.08M-1,241.54%-13.19M-166.58%-9.11M
Asset Impairment Loss 3,671.19%49.65K-----3,685.29%-19.62M---1.39K---1.39K---1.39K4.27%-518.22K------0--0
Adjustment items of total operating cost ---0.01-------------------0.01----------------
Other net revenue -78.09%3.19M-97.67%262.25K17.75%56.13M320.08%28.86M186.84%14.56M254.18%11.24M-23.31%47.67M-124.54%-13.11M-5,077.46%-16.76M-69.42%-7.29M
Fair value change income 165.15%858.81K158.63%430.73K670.53%771.38K122.09%440.84K-10.05%323.9K-63.32%166.55K-89.88%100.11K8.78%198.5K135.87%360.09K599.76%454.06K
Invest income -41.87%549.37K972.47%3.03M270.72%8M143.66%3.65M112.33%945.07K127.73%282.36K-1,244.58%-4.69M-19.26%-8.35M4.60%-7.67M84.45%-1.02M
Asset deal income --0-----55.98%25.35M--208.74--0------57.59M------------
Other revenue 10.67%5.35M10.95%2.87M135.25%24.2M32.99%8.14M29.65%4.84M8.15%2.59M6.76%10.28M-28.62%6.12M-47.21%3.73M-57.31%2.39M
Operating profit 51.88%204.55M14.45%117.01M-43.24%204.36M-20.18%194.34M-23.40%134.68M8.97%102.23M71.97%360.01M12.35%243.46M62.45%175.83M36.94%93.82M
Add:Non operating Income 688.36%1.12M-98.63%1.83K-52.01%350.92K-56.69%25.5M-99.76%141.92K-99.77%133.89K79.92%731.23K14,884.84%58.89M18,480.51%58.58M18,518.53%58.14M
Less:Non operating expense 254.59%231.2K1,636.66%174.4K190.70%1.18M174.83%1.07M-78.49%65.2K-93.47%10.04K10.96%407.28K15.18%388.05K32.25%303.18K20.14%153.74K
Total profit 52.45%205.44M14.15%116.83M-43.52%203.52M-27.55%218.78M-42.44%134.76M-32.57%102.36M72.10%360.33M39.31%301.96M116.13%234.11M120.99%151.8M
Less:Income tax cost 37.56%29.01M-17.64%15.49M-38.52%24.85M-30.47%31.12M-45.03%21.09M-27.69%18.81M75.47%40.42M36.61%44.76M65.62%38.36M82.74%26.01M
Net profit 55.21%176.43M21.30%101.35M-44.15%178.67M-27.04%187.65M-41.93%113.67M-33.58%83.55M71.68%319.91M39.79%257.2M129.87%195.75M130.98%125.8M
Net profit from continuing operation 55.21%176.43M21.30%101.35M-44.15%178.67M-27.04%187.65M-41.93%113.67M-33.58%83.55M71.68%319.91M39.79%257.2M129.87%195.75M130.98%125.8M
Less:Minority Profit -18.84%-6.37M-15.20%-2.76M8.99%-3.19M8.91%-10.2M12.35%-5.36M2.22%-2.4M-166.56%-3.5M-88.67%-11.2M-53.03%-6.11M-2,507.97%-2.45M
Net profit of parent company owners 53.57%182.79M21.13%104.11M-43.77%181.86M-26.28%197.86M-41.03%119.03M-32.98%85.95M78.60%323.41M41.32%268.4M126.42%201.86M135.93%128.25M
Earning per share
Basic earning per share 56.50%0.145723.07%0.0827-44.00%0.14-27.68%0.1549-42.35%0.0931-34.50%0.067266.67%0.2540.74%0.2142125.87%0.1615135.32%0.1026
Diluted earning per share 56.50%0.145723.07%0.0827-44.00%0.14-27.68%0.1549-42.35%0.0931-34.50%0.067266.67%0.2540.74%0.2142125.87%0.1615135.32%0.1026
Other composite income -81.04%-741.72K-2,850.69%-1.32M118.33%420.5K56.43%-1.57M-159.64%-409.7K-106.87%-44.83K-173.72%-2.29M-14,922.82%-3.59M4,878.38%687K2,266.05%652.35K
Other composite income of parent company owners -81.04%-741.72K-2,850.69%-1.32M118.33%420.5K56.43%-1.57M-159.64%-409.7K-106.87%-44.83K-173.72%-2.29M-14,922.82%-3.59M4,878.38%687K2,266.05%652.35K
Total composite income 55.12%175.69M19.78%100.02M-43.61%179.09M-26.62%186.09M-42.34%113.26M-33.96%83.51M67.65%317.62M37.86%253.61M130.71%196.43M132.06%126.45M
Total composite income of parent company owners 53.48%182.05M19.65%102.79M-43.24%182.28M-25.87%196.29M-41.44%118.62M-33.36%85.9M74.34%321.12M39.45%264.81M127.23%202.54M137.01%128.9M
Total composite income of minority owners -18.84%-6.37M-15.20%-2.76M8.99%-3.19M8.91%-10.2M12.35%-5.36M2.22%-2.4M-166.56%-3.5M-88.67%-11.2M-53.03%-6.11M-2,507.97%-2.45M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Notarized Tianye Certified Public Accountants (Special General Partnership)------Notarized Tianye Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg